Skip to content

Latest disclosed trades

Every stock trade disclosed by members of Congress, the executive branch and company insiders — newest first.

See the trades

Updated Oct 17 · 2 feeds behind: Insider filings, 3 days, and 1 more · Every feed →

All 63Congress 0Executive branch 0Insiders 63
AllBuysSells
Filed late
More filters
DemRepInd
HouseSenateExecutive
$15K+$50K+$100K+$250K+$1M+
Clear filters

ARTV · $250K+ · 63 trades

Trades
63
Buys 60 · Sells 3
People
7
Stocks
1
Disclosed value
$102M
range midpoints · Congress & executive
Filed late
0
  1. ▲ BUYRA Capital Nexus Fund III, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$1.1Mdisclosed Jun 16 · filed the same day
  2. ▲ BUYRA Capital Healthcare Fund LP DirectorARTV Artiva Biotherapeutics, Inc.$3.3Mdisclosed Jun 11 · filed 2 days after the trade
  3. ▲ BUYRajeev M. Shah DirectorARTV Artiva Biotherapeutics, Inc.$3.3Mdisclosed Jun 11 · filed 2 days after the trade
  4. ▲ BUYPeter Kolchinsky DirectorARTV Artiva Biotherapeutics, Inc.$4.3Mdisclosed Jun 11 · filed the same day
  5. ▲ BUYRajeev M. Shah DirectorARTV Artiva Biotherapeutics, Inc.$4.3Mdisclosed Jun 11 · filed the same day
  6. ▲ BUYRA Capital Healthcare Fund LP DirectorARTV Artiva Biotherapeutics, Inc.$4.3Mdisclosed Jun 11 · filed the same day
  7. ▲ BUYRA Capital Nexus Fund, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$3.3Mdisclosed Jun 11 · filed 2 days after the trade
  8. ▲ BUYRA Capital Nexus Fund, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$4.3Mdisclosed Jun 11 · filed the same day
  9. ▲ BUYRa Capital Management, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$3.3Mdisclosed Jun 11 · filed 2 days after the trade
  10. ▲ BUYRa Capital Management, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$4.3Mdisclosed Jun 11 · filed the same day
  11. ▲ BUYRA Capital Nexus Fund III, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$3.3Mdisclosed Jun 11 · filed 2 days after the trade
  12. ▲ BUYPeter Kolchinsky DirectorARTV Artiva Biotherapeutics, Inc.$3.3Mdisclosed Jun 11 · filed 2 days after the trade
  13. ▲ BUYRA Capital Nexus Fund III, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$4.3Mdisclosed Jun 11 · filed the same day